Press Releases Events & Presentations Event Details 48th Annual International Herpesvirus Workshop (IHW) Jul 13 - Jul 17, 2024 Supporting Materials ABI-5366 - The Helicase-Primase Inhibitor ABI-5366 Is a Novel, Potent, Long-Acting Inhibitor for the Treatment of Recurrent Genital Herpes 544.4 KB ABI-1179 - Preclinical Characterization of ABI-1179, a Potent Helicase Primase Inhibitor for the Treatment of Recurrent Genital Herpes 1.2 MB ABI-1179 - Preclinical Characterization of ABI-1179, a Potent Helicase Primase Inhibitor for the Treatment of Recurrent Genital Herpes (oral presentation) 744.1 KB Shareholder Tools Print Email Alerts RSS News Feeds Search Investors
48th Annual International Herpesvirus Workshop (IHW) Jul 13 - Jul 17, 2024 Supporting Materials ABI-5366 - The Helicase-Primase Inhibitor ABI-5366 Is a Novel, Potent, Long-Acting Inhibitor for the Treatment of Recurrent Genital Herpes 544.4 KB ABI-1179 - Preclinical Characterization of ABI-1179, a Potent Helicase Primase Inhibitor for the Treatment of Recurrent Genital Herpes 1.2 MB ABI-1179 - Preclinical Characterization of ABI-1179, a Potent Helicase Primase Inhibitor for the Treatment of Recurrent Genital Herpes (oral presentation) 744.1 KB
ABI-5366 - The Helicase-Primase Inhibitor ABI-5366 Is a Novel, Potent, Long-Acting Inhibitor for the Treatment of Recurrent Genital Herpes 544.4 KB
ABI-1179 - Preclinical Characterization of ABI-1179, a Potent Helicase Primase Inhibitor for the Treatment of Recurrent Genital Herpes 1.2 MB
ABI-1179 - Preclinical Characterization of ABI-1179, a Potent Helicase Primase Inhibitor for the Treatment of Recurrent Genital Herpes (oral presentation) 744.1 KB
